MEDAVAIL HOLDINGS INC's ticker is MDVL and the CUSIP is 58406B103. A total of 42 filers reported holding MEDAVAIL HOLDINGS INC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $24,957 | -48.7% | 101,822 | -40.1% | 0.00% | – |
| Q1 2023 | $48,688 | -2.8% | 169,880 | +1.7% | 0.00% | – |
| Q4 2022 | $50,085 | -60.9% | 167,060 | +1.1% | 0.00% | – |
| Q3 2022 | $128,000 | -50.0% | 165,180 | -1.4% | 0.00% | – |
| Q2 2022 | $256,000 | -51.1% | 167,530 | -68.8% | 0.00% | – |
| Q1 2022 | $523,000 | -31.6% | 537,738 | -1.5% | 0.00% | – |
| Q4 2021 | $765,000 | -51.2% | 545,849 | +1.6% | 0.00% | – |
| Q3 2021 | $1,569,000 | -76.1% | 537,032 | +0.3% | 0.00% | – |
| Q2 2021 | $6,562,000 | – | 535,600 | +2142300.0% | 0.00% | – |
| Q1 2021 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 15,029,480 | $22,995,000 | 81.12% |
| Ally Bridge Group (NY) LLC | 5,894,897 | $9,019,000 | 8.22% |
| Redmile Group, LLC | 25,192,751 | $38,545,000 | 1.47% |
| CIGNA INVESTMENTS INC /NEW | 2,389,478 | $3,656,000 | 0.73% |
| Alyeska Investment Group, L.P. | 7,529,411 | $11,520,000 | 0.13% |
| PURA VIDA INVESTMENTS, LLC | 714,120 | $1,093,000 | 0.06% |
| Alpha Paradigm Partners, LLC | 57,539 | $88,000,000 | 0.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 836,626 | $1,280,000 | 0.03% |
| Belvedere Trading LLC | 242,100 | $332,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $1,530,000 | 0.00% |